Do Diagnostic Nerve Blocks Affect the Starting Dose of Botulinum Neurotoxin Type A for Spasticity? A Case-Control Study

Do Diagnostic Nerve Blocks Affect the Starting Dose of Botulinum Neurotoxin Type A for Spasticity? A Case-Control Study

One of the aims of diagnostic nerve blocks is to identify the overactive muscles that lead to a specific spasticity pattern. However, to date, there is no evidence on how nerve blocks may affect botulinum neurotoxin-A (BoNT-A) dose in patients with spasticity. This case-control study aims to assess...

Full description

Saved in:
Bibliographic Details
Main Authors: Mirko Filippetti, Stefano Tamburin, Rita Di Censo, Roberto Aldegheri, Elisa Mantovani, Stefania Spina, Marco Battaglia, Alessio Baricich, Andrea Santamato, Nicola Smania, Alessandro Picelli
Format: Article
Language:English
Published: MDPI AG 2024-09-01
Series:Toxins
Subjects:
botulinum neurotoxin
drug utilization
muscle spasticity
nerve block
ultrasonography
Online Access:https://www.mdpi.com/2072-6651/16/9/388
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items